[Experimental purulent meningitis and its treatment with antibiotics].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000378:metabolism / Q000627:therapeutic use; D005672:Fusidic Acid / Q000009:adverse effects / Q000378:metabolism; D007275:Injections, Intravenous; D008581:Meningitis / Q000188:drug therapy*; D010068:Oxacillin / Q000378:metabolism / Q000627:therapeutic use; D010403:Penicillin Resistance; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000139:chemically induced; D013997:Time Factors
D000900:Anti-Bacterial Agents; D005672:Fusidic Acid; D002228:Carbenicillin; D010068:Oxacillin
Eksperimental'nyĭ gnoĭyĭ meningit i ego lechenie antibiotikami